Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Eccentric muscle challenge shows osteopontin polymorphism modulation of muscle damage.

Barfield WL, Uaesoontrachoon K, Wu CS, Lin S, Chen Y, Wang PC, Kanaan Y, Bond V, Hoffman EP.

Hum Mol Genet. 2014 Aug 1;23(15):4043-50. doi: 10.1093/hmg/ddu118. Epub 2014 Mar 13.

2.

TGFBR2 but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle.

Piva L, Gavassini BF, Bello L, Fanin M, Soraru G, Barp A, Ermani M, Angelini C, Hoffman EP, Pegoraro E.

J Pathol. 2012 Oct;228(2):251-9. doi: 10.1002/path.4026. Epub 2012 Aug 28.

3.

Alterations in osteopontin modify muscle size in females in both humans and mice.

Hoffman EP, Gordish-Dressman H, McLane VD, Devaney JM, Thompson PD, Visich P, Gordon PM, Pescatello LS, Zoeller RF, Moyna NM, Angelopoulos TJ, Pegoraro E, Cox GA, Clarkson PM.

Med Sci Sports Exerc. 2013 Jun;45(6):1060-8. doi: 10.1249/MSS.0b013e31828093c1.

4.

IL6 (-174) and TNFA (-308) promoter polymorphisms are associated with systemic creatine kinase response to eccentric exercise.

Yamin C, Duarte JA, Oliveira JM, Amir O, Sagiv M, Eynon N, Sagiv M, Amir RE.

Eur J Appl Physiol. 2008 Oct;104(3):579-86. doi: 10.1007/s00421-008-0728-4. Epub 2008 Aug 30.

PMID:
18758806
5.

SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy.

Pegoraro E, Hoffman EP, Piva L, Gavassini BF, Cagnin S, Ermani M, Bello L, Soraru G, Pacchioni B, Bonifati MD, Lanfranchi G, Angelini C, Kesari A, Lee I, Gordish-Dressman H, Devaney JM, McDonald CM; Cooperative International Neuromuscular Research Group.

Neurology. 2011 Jan 18;76(3):219-26. doi: 10.1212/WNL.0b013e318207afeb. Epub 2010 Dec 22.

6.

The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor.

Schultz J, Lorenz P, Ibrahim SM, Kundt G, Gross G, Kunz M.

Mol Carcinog. 2009 Jan;48(1):14-23. doi: 10.1002/mc.20452.

PMID:
18459127
7.

Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy.

Bello L, Piva L, Barp A, Taglia A, Picillo E, Vasco G, Pane M, Previtali SC, Torrente Y, Gazzerro E, Motta MC, Grieco GS, Napolitano S, Magri F, D'Amico A, Astrea G, Messina S, Sframeli M, Vita GL, Boffi P, Mongini T, Ferlini A, Gualandi F, Soraru' G, Ermani M, Vita G, Battini R, Bertini E, Comi GP, Berardinelli A, Minetti C, Bruno C, Mercuri E, Politano L, Angelini C, Hoffman EP, Pegoraro E.

Neurology. 2012 Jul 10;79(2):159-62. doi: 10.1212/WNL.0b013e31825f04ea. Epub 2012 Jun 27.

8.

OPN -443C>T genetic polymorphism and tumor OPN expression are associated with the risk and clinical features of papillary thyroid cancer in a Chinese cohort.

Mu G, Wang H, Cai Z, Ji H.

Cell Physiol Biochem. 2013;32(1):171-9. doi: 10.1159/000350133. Epub 2013 Jul 12.

PMID:
23867349
9.

Polymorphisms in the osteopontin promoter affect its transcriptional activity.

Giacopelli F, Marciano R, Pistorio A, Catarsi P, Canini S, Karsenty G, Ravazzolo R.

Physiol Genomics. 2004 Dec 15;20(1):87-96. Epub 2004 Oct 12.

10.

Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis.

Chen Y, Liu H, Wu W, Li Y, Li J.

J Exp Clin Cancer Res. 2013 Jul 24;32:45. doi: 10.1186/1756-9966-32-45.

11.

The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis.

Liu CC, Huang SP, Tsai LY, Wu WJ, Juo SH, Chou YH, Huang CH, Wu MT.

Clin Chim Acta. 2010 May 2;411(9-10):739-43. doi: 10.1016/j.cca.2010.02.007. Epub 2010 Feb 6.

PMID:
20144595
12.

The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis.

Chiu YW, Tu HF, Wang IK, Wu CH, Chang KW, Liu TY, Kao SY.

Oral Oncol. 2010 Apr;46(4):302-6. doi: 10.1016/j.oraloncology.2010.01.018. Epub 2010 Mar 9.

PMID:
20219412
13.

The extrapituitary prolactin promoter polymorphism is associated with rheumatoid arthritis and anti-CCP antibodies in Mexican population.

Reyes-Castillo Z, Pereira-Suárez AL, Palafox-Sanchez CA, Rangel-Villalobos H, Estrada-Chávez C, Oregón-Romero E, Angel-Chávez LI, Muñoz-Barrios S, Bueno-Topete MR, Muñoz-Valle JF.

Gene. 2013 Aug 1;525(1):130-5. doi: 10.1016/j.gene.2013.04.068. Epub 2013 May 7.

PMID:
23660301
14.

Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype.

Brioschi S, Gualandi F, Scotton C, Armaroli A, Bovolenta M, Falzarano MS, Sabatelli P, Selvatici R, D'Amico A, Pane M, Ricci G, Siciliano G, Tedeschi S, Pini A, Vercelli L, De Grandis D, Mercuri E, Bertini E, Merlini L, Mongini T, Ferlini A.

BMC Med Genet. 2012 Aug 16;13:73.

15.

The promoter polymorphism of the interleukin-6 gene regulates interleukin-6 production in neonates but not in adults.

Kilpinen S, Hulkkonen J, Wang XY, Hurme M.

Eur Cytokine Netw. 2001 Mar;12(1):62-8.

PMID:
11282548
16.

The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease.

Glas J, Seiderer J, Bayrle C, Wetzke M, Fries C, Tillack C, Olszak T, Beigel F, Steib C, Friedrich M, Diegelmann J, Czamara D, Brand S.

PLoS One. 2011;6(12):e29309. doi: 10.1371/journal.pone.0029309. Epub 2011 Dec 29.

17.

Osteopontin gene polymorphism in association with systemic lupus erythematosus in Chinese patients.

Xu AP, Bai J, Lü J, Liang YY, Li JG, Lai DY, Wan X, Huang HH.

Chin Med J (Engl). 2007 Dec 5;120(23):2124-8.

PMID:
18167187
18.
19.

TIS7 regulation of the beta-catenin/Tcf-4 target gene osteopontin (OPN) is histone deacetylase-dependent.

Vietor I, Kurzbauer R, Brosch G, Huber LA.

J Biol Chem. 2005 Dec 2;280(48):39795-801. Epub 2005 Oct 3.

20.

Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice.

Martin PT, Xu R, Rodino-Klapac LR, Oglesbay E, Camboni M, Montgomery CL, Shontz K, Chicoine LG, Clark KR, Sahenk Z, Mendell JR, Janssen PM.

Am J Physiol Cell Physiol. 2009 Mar;296(3):C476-88. doi: 10.1152/ajpcell.00456.2008. Epub 2008 Dec 24.

Items per page

Supplemental Content

Write to the Help Desk